| European Case Law Identifier: | ECLI:EP:BA:2003:T080301.20030909 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 09 September 2003 | ||||||||
| Case number: | T 0803/01 | ||||||||
| Application number: | 97202586.0 | ||||||||
| IPC class: | C08G 63/90 | ||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | B | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | Purified polylactide and pharmaceutical composition thereof | ||||||||
| Applicant name: | Novartis AG | ||||||||
| Opponent name: | - | ||||||||
| Board: | 3.3.03 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: |
|
||||||||
| Keywords: | Claims - clarity (yes) Novelty - purity of a polymeric compound a new element (yes) Inventive step (yes) |
||||||||
| Catchwords: |
The question of whether a degree of purity of a compund provides a new element over the prior art must be sought in the concrete technical context concerned (reasons, point 4.6) |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t010803eu1.html
Date retrieved: 17 May 2021